This inventor holds 3 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Novartis Ag, Camurus Ab. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Muespach le Hauf, FR (2012)
- Basel, CH (2013)
Company Filing History:
Years Active: 2012-2025
Title: David Hemmerlin: Innovator in Pharmaceutical Compositions
Introduction
David Hemmerlin, an accomplished inventor based in Basel, Switzerland, holds an impressive portfolio with three patents to his name. His innovative contributions predominantly focus on lipid-controlled release compositions and advanced packaging solutions, underscoring his expertise in pharmaceutical technology.
Latest Patents
Among his noteworthy inventions, Hemmerlin's latest patents include:
1. **Lipid-Controlled Release Compositions**
This patent features a glass syringe or cartridge designed for parenteral administration. The composition comprises a lipid-based pre-formulation suitable for refrigerated storage, made up of 20-80 wt % diacyl glycerol predominantly comprising oleic acid, along with phospholipids, solvents, and bioactive agents. This innovative formulation aims to improve drug delivery methods in pharmaceuticals.
2. **Pouch Having Tear Strip**
Another significant invention is a pouch engineered to enhance product accessibility. This pouch features a first and second wall sealed around a compartment. It includes a tear strip that allows for easy opening without compromising the contents, making it practical for various products. The design integrates tear guiding regions to facilitate a smooth tearing process, ensuring user-friendly access.
Career Highlights
Throughout his career, Hemmerlin has achieved significant milestones, working with prominent companies in the pharmaceutical sector, including Novartis AG and Camurus AB. His involvement in these organizations has allowed him to contribute directly to the advancement of drug formulation and delivery systems.
Collaborations
David Hemmerlin has collaborated with talented professionals in the field, including Francis Lovell and Isabelle Suire. These partnerships have enhanced his research and innovation capabilities, fostering a collaborative environment that drives advancements in pharmaceutical technologies.
Conclusion
David Hemmerlin continues to be a pivotal figure in the realm of pharmaceutical innovations. His patents not only reflect his technical acumen but also signify his commitment to enhancing drug delivery systems and product packaging solutions. As he progresses in his career, Hemmerlin's contributions are expected to pave the way for future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile